Mineralys Therapeutics
MLYS
MLYS
106 hedge funds and large institutions have $540M invested in Mineralys Therapeutics in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
13% more funds holding
Funds holding: 94 → 106 (+12)
5% more capital invested
Capital invested by funds: $517M → $540M (+$23.5M)
0.32% more ownership
Funds ownership: 88.92% → 89.25% (+0.32%)
Holders
106
Holding in Top 10
7
Calls
$109K
Puts
$66K
Top Buyers
| 1 | +$8.53M | |
| 2 | +$4.31M | |
| 3 | +$3.57M | |
| 4 |
CP
Caligan Partners
New York
|
+$2.85M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$2.28M |
Top Sellers
| 1 | -$8.66M | |
| 2 | -$6.66M | |
| 3 | -$4.43M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$3.21M |
| 5 |
BOCH
Blue Owl Capital Holdings
New York
|
-$3.08M |